BioGaia AB (Sweden) Price Prediction
| BIOG-B Stock | SEK 105.80 0.40 0.38% |
Oversold Vs Overbought
47
Oversold | Overbought |
Using BioGaia AB hype-based prediction, you can estimate the value of BioGaia AB from the perspective of BioGaia AB response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in BioGaia AB to buy its stock at a price that has no basis in reality. In that case, they are not buying BioGaia because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
BioGaia AB after-hype prediction price | SEK 105.8 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BioGaia |
BioGaia AB After-Hype Price Prediction Density Analysis
As far as predicting the price of BioGaia AB at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in BioGaia AB or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of BioGaia AB, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
BioGaia AB Estimiated After-Hype Price Volatility
In the context of predicting BioGaia AB's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on BioGaia AB's historical news coverage. BioGaia AB's after-hype downside and upside margins for the prediction period are 104.30 and 107.30, respectively. We have considered BioGaia AB's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
BioGaia AB is very steady at this time. Analysis and calculation of next after-hype price of BioGaia AB is based on 3 months time horizon.
BioGaia AB Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as BioGaia AB is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BioGaia AB backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with BioGaia AB, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 1.50 | 0.00 | 0.00 | 0 Events / Month | 0 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
105.80 | 105.80 | 0.00 |
|
BioGaia AB Hype Timeline
BioGaia AB is currently traded for 105.80on Stockholm Exchange of Sweden. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. BioGaia is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at -0.16%. %. The volatility of related hype on BioGaia AB is about 0.0%, with the expected price after the next announcement by competition of 105.80. About 50.0% of the company shares are held by institutions such as insurance companies. The book value of BioGaia AB was currently reported as 19.53. The company has Price/Earnings To Growth (PEG) ratio of 1.9. BioGaia AB last dividend was issued on the 9th of May 2022. The entity had 5:1 split on the 18th of May 2022. Assuming the 90 days trading horizon the next estimated press release will be in 5 to 10 days. Check out BioGaia AB Basic Forecasting Models to cross-verify your projections.BioGaia AB Related Hype Analysis
Having access to credible news sources related to BioGaia AB's direct competition is more important than ever and may enhance your ability to predict BioGaia AB's future price movements. Getting to know how BioGaia AB's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how BioGaia AB may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| BIOT | Biotage AB | 0.00 | 0 per month | 0.00 | (0.23) | 2.78 | (4.27) | 9.07 | |
| CEVI | CellaVision AB | 0.00 | 0 per month | 0.00 | (0.20) | 2.94 | (3.95) | 13.59 | |
| SECT-B | Sectra AB | 0.00 | 0 per month | 1.44 | 0.1 | 2.77 | (2.77) | 8.87 | |
| EKTA-B | Elekta AB | 0.00 | 0 per month | 0.00 | (0.14) | 2.62 | (2.33) | 7.62 | |
| PROB | Probi AB | 0.00 | 0 per month | 2.51 | 0.07 | 5.02 | (4.65) | 42.97 |
BioGaia AB Additional Predictive Modules
Most predictive techniques to examine BioGaia price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BioGaia using various technical indicators. When you analyze BioGaia charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About BioGaia AB Predictive Indicators
The successful prediction of BioGaia AB stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as BioGaia AB, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of BioGaia AB based on analysis of BioGaia AB hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to BioGaia AB's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to BioGaia AB's related companies.
Story Coverage note for BioGaia AB
The number of cover stories for BioGaia AB depends on current market conditions and BioGaia AB's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BioGaia AB is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BioGaia AB's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
BioGaia AB Short Properties
BioGaia AB's future price predictability will typically decrease when BioGaia AB's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BioGaia AB often depends not only on the future outlook of the potential BioGaia AB's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioGaia AB's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 101 M |
Complementary Tools for BioGaia Stock analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| CEOs Directory Screen CEOs from public companies around the world |